– Similar glucose lowering effect when once-daily Lyxumia is administered before breakfast or the main meal – PARIS, Dec. 5, 2013 /PRNewswire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the results of a 24-week Phase IIIb clinical study showing that Lyxumia® (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered either before breakfast […]
Imorgon’s Report Accelerator and Ultrasound View Dramatically Improve Productivity and Diagnostic Quality of Ultrasound CHICAGO, Dec. 2, 2013 – Imorgon, the developer of advanced integrated software solutions that enable the full potential of diagnostic ultrasound, announced today it will showcase its IntegratedUltrasound™ solution including the Ultrasound View and Report Accelerator at the 99th Scientific Assembly […]
Forest acquires exclusive rights to Saphris® in the United States for the treatment of schizophrenia and acute bipolar mania in adults for $240 million plus sales-based milestones and on-going supply payments Saphris is complementary to Forest’s existing CNS franchise and commercial infrastructure Agreement is expected to be immediately accretive to Forest NEW YORK — December […]
PITTSBURGH, Dec. 1, 2013 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL), one of the world’s leading pharmaceutical companies, and the Elton John AIDS Foundation (EJAF) today announced that they will give a combined $1 million to the Business Leadership Council for a Generation Born HIV Free (BLC) for the elimination of mother-to-child transmission (eMTCT) of HIV […]
Global Musical Sensation to Headline the Royal Theater in November 2014 NEW YORK, Nov. 28, 2013 – Royal Caribbean International – the first cruise line to feature fully licensed, Tony Award-winning Broadway productions – today announced that guests onboard Quantum of the Seas will enjoy MAMMA MIA! – the smash hit musical based on the […]
LISBON, Portugal, Nov. 26, 2013 /PRNewswire/ — Leading oncology centers have reported on advances in stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR) treatments at the first Varian Edge™ Radiosurgery Symposium, held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. Experts from leading centers of excellence around the world presented details of the latest in advanced treatment […]
NEW YORK & BUDAPEST, Hungary– November 21, 2013 — (BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) and Gedeon Richter Plc. announced that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for cariprazine, an atypical antipsychotic for the treatment of schizophrenia and for the acute treatment of manic or […]
Global Ambassadors Program Will Focus on the Role of Mentoring Bank of America and Vital Voices today launched a weeklong joint mentoring forum in Doha, Qatar. The Global Ambassadors Program (GAP), which runs from November 11 through 15, brings together influential women leaders from the global public and private sectors with those from the Middle […]
NEW YORK–November 11, 2013–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) today announced that Robert Bailey was appointed Senior Vice President, Chief Legal Officer General Counsel. In this role, Bailey will be responsible to manage the legal affairs of the Company, and will also serve as the company’s Corporate Secretary. Bailey will report to Brent Saunders, Chief Executive […]
Will Reach Goal of 1,000 Donations More Than a Year Ahead of Schedule Wounded Army Sergeant James Miller and his family received keys to a mortgage-free home in a surprise ceremony in Victorville, Calif., today, becoming the latest servicemember to receive a home donated by Bank of America through nonprofit organizations. With today’s donation, Bank […]